Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1844-1849

  Nagaoka, Kentaro ^a,c   Yanagihara, Katsunori ^a   Harada, Yosuke ^a   Yamada, Koichi ^a   Migiyama, Yohei ^a   Morinaga, Yoshitomo ^a   Hasegawa, Hiroo ^a   Izumikawa, Koichi ^a   Kakeya, Hiroshi ^a   Nishimura, Masaharu ^c   Kohno, Shigeru ^a,b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; MACROLIDE; MESSENGER RNA; METRONIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUCIN 5AC;

ARTICLE; BRONCHUS MUCOSA; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUSOBACTERIUM NUCLEATUM; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENESIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

AZITHROMYCIN; CELL LINE; CLARITHROMYCIN; CLINDAMYCIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FUSOBACTERIUM NUCLEATUM; HUMANS; MACROLIDES; METRONIDAZOLE; MUCIN 5AC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84875124859     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02466-12     Document Type: Article

References (26)

1. Dohrman A, Miyata S, Gallup M, Li JD, Chapelin C, Coste A, Escudier E, Nadel J, Basbaum C. 1998. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim. Biophys. Acta 1406:251-259.
2. Shimizu T, Shimizu S, Hattori R, Gabazza EC, Majima Y. 2003. In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. Am. J. Respir. Crit. Care Med. 168:581-587.
3. Sjögren P, Nilsson E, Forsell M, Johansson O, Hoogstraate J. 2008. A systematic review of the preventive effect of oral hygiene on pneumonia and respiratory tract infection in elderly people in hospitals and nursing homes: effect estimates and methodological quality of randomized controlled trials. J. Am. Geriatr. Soc. 56:2124-2130.
4. Adachi M, Ishihara K, Abe S, Okuda K, Ishikawa T. 2002. Effect of professional oral health care on the elderly living in nursing homes. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 94:191-195.
5. DeRiso AJ, II, Ladowski JS, Dillon TA, Justice JW, Peterson AC. 1996. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 109:1556-1561.
6. Yoneyama T, Yoshida M, Matsui T, Sasaki H. 1999. Oral care and pneumonia. Lancet 354:515.
7. Yoneyama T, Yoshida M, Ohrui T, Mukaiyama H, Okamoto H, Hoshiba K, Ihara S, Yanagisawa S, Ariumi S, Morita T, Mizuno Y, Ohsawa T, Akagawa Y, Hashimoto K, Sasaki H; Oral Care Working Group. 2002. Oral care reduces pneumonia in older patients in nursing homes. J. Am. Geriatr. Soc. 50:430-433.
8. Signat B, Roques C, Poulet P, Duffaut D. 2011. Fusobacterium nucleatum in periodontal health and disease. Curr. Issues Mol. Biol. 13:25-36.
9. Imai K, Ochiai K. 2011. Role of histone modification on transcriptional regulation and HIV-1 gene expression: possible mechanisms of periodontal diseases in AIDS progression. J. Oral Sci. 53:1-13.
10. Imai K, Yamada K, Tamura M, Ochiai K, Okamoto T. 2012. Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria. Cell. Mol. Life Sci. 69:2583-2592.
11. Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. 2003. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52:79- 83.
12. Azarpazhooh A, Leake JL. 2006. Systematic review of the association between respiratory diseases and oral health. J. Periodontol. 77:1465-1482.
13. Marik PE, Kaplan D. 2003. Aspiration pneumonia and dysphagia in the elderly. Chest 124:328-336.
14. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. 1998. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am. J. Respir. Crit. Care Med. 157:1829-1832.
15. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW, III. 2003. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290: 1749-1756.
16. Giamarellos-Bourboulis EJ. 2008. Immunomodulatory therapies for sepsis: unexpected effects with macrolides. Int. J. Antimicrob. Agents 32(Suppl 1):39-43.
17. Imamura Y, Yanagihara K, Mizuta Y, Seki M, Ohno H, Higashiyama Y, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Kohno S. 2004. Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NCI-H292 cells. Antimicrob. Agents Chemother. 48:3457-3461.
18. Ishimoto H, Mukae H, Sakamoto N, Amenomori M, Kitazaki T, Imamura Y, Fujita H, Ishii H, Nakayama S, Yanagihara K, Kohno S. 2009. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. J. Antimicrob. Chemother. 63:109-114.
19. Araki N, Yanagihara K, Morinaga Y, Yamada K, Nakamura S, Yamada Y, Kohno S, Kamihira S. 2010. Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cells. Eur. J. Pharmacol. 644:209-214.
20. Morinaga Y, Yanagihara K, Miyashita N, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Mukae H, Yamada Y, Kohno S, Kamihira S. 2009. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. Pulm. Pharmacol. Ther. 22:580-586.
21. Inoue D, Yamaya M, Kubo H, Sasaki T, Hosoda M, Numasaki M, Tomioka Y, Yasuda H, Sekizawa K, Nishimura H, Sasaki H. 2006. Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells. Respir. Physiol. Neurobiol. 154:484-499.
22. Giamarellos-Bourboulis EJ, Pechère JC, Routsi C, Plachouras D, Kollias S, Raftogiannis M, Zervakis D, Baziaka F, Koronaios A, Antonopoulou A, Markaki V, Koutoukas P, Papadomichelakis E, Tsaganos T, Armaganidis A, Koussoulas V, Kotanidou A, Roussos C, Giamarellou H. 2008. Effect of clarithromycin in patients with sepsis and ventilatorassociated pneumonia. Clin. Infect. Dis. 46:1157-1164.
23. Lappin E, Ferguson AJ. 2009. Gram-positive toxic shock syndromes. Lancet Infect. Dis. 9:281-290.
24. Pichereau S, Moran JJ, Hayney MS, Shukla SK, Sakoulas G, Rose WE. 2012. Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells. J. Antimicrob. Chemother. 67:123-129.
25. Rizzo A, Paolillo R, Guida L, Annunziata M, Bevilacqua N, Tufano MA. 2010. Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells. Int. Immunopharmacol. 10:744-750.
26. Selsted ME, Ouellette AJ. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551-557.